News
OMCL
46.40
+1.35%
0.62
Weekly Report: what happened at OMCL last week (1222-1226)?
Weekly Report · 3h ago
FLGT to Acquire Bako & StrataDx Assets to Expand Pathology Platform
NASDAQ · 5d ago
Omnicell (OMCL) valuation check as new Titan XT automation platform targets healthcare growth
Simply Wall St · 6d ago
Weekly Report: what happened at OMCL last week (1215-1219)?
Weekly Report · 12/22 09:31
Omnicell (OMCL) Gets a Buy from Piper Sandler
TipRanks · 12/19 11:48
The Bull Case For Omnicell (OMCL) Could Change Following Titan XT AI Medication Platform Launch
Simply Wall St · 12/18 06:30
Omnicell EVP and Chief Legal/Admin Officer Corey J. Manley Reports Disposal of Common Shares
Reuters · 12/17 21:06
How the OneStep Partnership Could Drive Growth for ZBH Stock
NASDAQ · 12/17 12:58
Wells Fargo’s ‘tariff relief’ beneficiaries ranked by SA Quant metrics
Seeking Alpha · 12/16 16:54
Best Momentum Stocks to Buy for Dec. 16
NASDAQ · 12/16 15:00
New Strong Buy Stocks for Dec. 16: MDB, OMCL, and More
NASDAQ · 12/16 10:43
Weekly Report: what happened at OMCL last week (1208-1212)?
Weekly Report · 12/15 09:34
Taking Stock of Omnicell (OMCL) After Titan XT Launch: What the New Platform Means for Valuation
Simply Wall St · 12/15 03:21
Is it Worth Retaining NEOG Stock in Your Portfolio for Now?
NASDAQ · 12/10 13:34
Phibro Animal Health Stock Climbs 59.6% YTD: What's Driving It?
NASDAQ · 12/10 13:31
Is Omnicell’s (OMCL) Titan XT Launch a Turning Point in Its SaaS Automation Strategy?
Simply Wall St · 12/09 23:24
Omnicell price target raised to $46 from $36 at BofA
TipRanks · 12/09 19:55
Omnicell Price Target Raised to $50.00/Share From $45.00 by Benchmark
Dow Jones · 12/09 13:23
Omnicell Is Maintained at Buy by Benchmark
Dow Jones · 12/09 13:23
Benchmark Maintains Buy on Omnicell, Raises Price Target to $50
Benzinga · 12/09 13:12
More
Webull provides a variety of real-time OMCL stock news. You can receive the latest news about Omnicell Com through multiple platforms. This information may help you make smarter investment decisions.
About OMCL
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.